11,703 Shares in Ventas, Inc. $VTR Bought by Bleakley Financial Group LLC

Bleakley Financial Group LLC purchased a new stake in shares of Ventas, Inc. (NYSE:VTR) in the 4th quarter, HoldingsChannel reports. The firm purchased 11,703 shares of the real estate investment trust’s stock, valued at approximately $906,000.

A number of other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in shares of Ventas by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock worth $5,876,856,000 after purchasing an additional 2,349,176 shares during the period. UBS Group AG boosted its position in shares of Ventas by 142.4% during the third quarter. UBS Group AG now owns 3,507,841 shares of the real estate investment trust’s stock valued at $245,514,000 after purchasing an additional 2,060,770 shares in the last quarter. Lasalle Investment Management Securities LLC lifted its holdings in shares of Ventas by 1,135.1% during the third quarter. Lasalle Investment Management Securities LLC now owns 1,552,880 shares of the real estate investment trust’s stock valued at $108,686,000 after purchasing an additional 1,427,151 shares during the last quarter. PGGM Investments purchased a new position in shares of Ventas during the fourth quarter valued at approximately $98,686,000. Finally, Invesco Ltd. lifted its holdings in shares of Ventas by 21.5% during the third quarter. Invesco Ltd. now owns 5,847,604 shares of the real estate investment trust’s stock valued at $409,274,000 after purchasing an additional 1,034,634 shares during the last quarter. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Insider Buying and Selling

In related news, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the sale, the director owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This represents a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is owned by insiders.

Ventas Price Performance

Shares of VTR stock opened at $84.55 on Friday. The company’s 50-day simple moving average is $85.30 and its two-hundred day simple moving average is $82.24. Ventas, Inc. has a one year low of $61.76 and a one year high of $91.06. The company has a market capitalization of $41.10 billion, a P/E ratio of 153.72, a P/E/G ratio of 1.89 and a beta of 0.74. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25.

Ventas (NYSE:VTR) last released its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the business posted $0.84 earnings per share. Ventas’s revenue for the quarter was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, equities analysts anticipate that Ventas, Inc. will post 3.88 EPS for the current year.

Ventas Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Ventas’s dividend payout ratio is presently 378.18%.

Wall Street Analysts Forecast Growth

VTR has been the subject of several analyst reports. Weiss Ratings reissued a “buy (b-)” rating on shares of Ventas in a research report on Friday, March 27th. Wells Fargo & Company lifted their price target on shares of Ventas from $88.00 to $93.00 and gave the stock an “overweight” rating in a research note on Thursday, March 26th. The Goldman Sachs Group restated a “buy” rating and set a $110.00 target price on shares of Ventas in a research note on Tuesday, May 19th. Royal Bank Of Canada lifted their target price on shares of Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Finally, Mizuho set a $98.00 price target on shares of Ventas in a research note on Friday, May 22nd. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $95.00.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.